1
Quist, S. W., Postma, A. J., Myrén, K. J., de Jong, L. A., Postma, M. J.
Veröffentlicht in: Quist , S W , Postma , A J , Myrén , K J , de Jong , L A & Postma , M J 2023 , ' Cost-effectiveness of ravulizumab compared with eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria in the Netherlands ' , European Journal of Health Economics . https://doi.org/10.1007/s10198-022-01556-5;
2023
Veröffentlicht in: Quist , S W , Postma , A J , Myrén , K J , de Jong , L A & Postma , M J 2023 , ' Cost-effectiveness of ravulizumab compared with eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria in the Netherlands ' , European Journal of Health Economics . https://doi.org/10.1007/s10198-022-01556-5;
2023
2
Stevanovic, J., de Jong, L. A., Kappelhoff, B. S., Dvortsin, E. P., Voorhaar, M., Postma, M. J.
Veröffentlicht in: Stevanovic , J , de Jong , L A , Kappelhoff , B S , Dvortsin , E P , Voorhaar , M & Postma , M J 2016 , ' Dabigatran for the Treatment and Secondary Prevention of Venous Thromboembolism; A Cost-Effectiveness Analysis for the Netherlands ' , PLoS ONE , vol. 11 , no. 10 , e0163550 . https://doi.org/10.1371/journal.pone.0163550;
2016
Veröffentlicht in: Stevanovic , J , de Jong , L A , Kappelhoff , B S , Dvortsin , E P , Voorhaar , M & Postma , M J 2016 , ' Dabigatran for the Treatment and Secondary Prevention of Venous Thromboembolism; A Cost-Effectiveness Analysis for the Netherlands ' , PLoS ONE , vol. 11 , no. 10 , e0163550 . https://doi.org/10.1371/journal.pone.0163550;
2016
3
de Jong, L.A., Koops, M., Gout-Zwart, J.J., Beinema, M.J., Hemels, M.E.W., Postma, M.J., Brouwers, J.R.B.J.
Veröffentlicht in: de Jong , L A , Koops , M , Gout-Zwart , J J , Beinema , M J , Hemels , M E W , Postma , M J & Brouwers , J R B J 2018 , ' Trends in direct oral anticoagulant (DOAC) use : Health benefits and patient preference ' , Netherlands Journal of Medicine , vol. 76 , no. 10 , pp. 426-430 .;
2018
Veröffentlicht in: de Jong , L A , Koops , M , Gout-Zwart , J J , Beinema , M J , Hemels , M E W , Postma , M J & Brouwers , J R B J 2018 , ' Trends in direct oral anticoagulant (DOAC) use : Health benefits and patient preference ' , Netherlands Journal of Medicine , vol. 76 , no. 10 , pp. 426-430 .;
2018